Results 1 to 10 of about 55,357 (300)

Botulinum toxin type A versus botulinum toxin type B for cervical dystonia [PDF]

open access: yesCochrane Database of Systematic Reviews, 2003
Cervical dystonia is the most common form of focal dystonia. It is characterized by involuntary posturing of the head and frequently is associated with neck pain. Disability and social withdrawal are common. Most cases are idiopathic, and generally it is a life-long disorder.
J, Costa   +6 more
core   +10 more sources

Cost-Effectiveness of Treating Upper Limb Spasticity Due to Stroke with Botulinum Toxin Type A: Results from the Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial [PDF]

open access: yesToxins, 2012
Stroke imposes significant burdens on health services and society, and as such there is a growing need to assess the cost-effectiveness of stroke treatment to ensure maximum benefit is derived from limited resources.
Nick Steen   +8 more
doaj   +5 more sources

Botulinum Toxin Type A for Pediatric Torticollis: A Review of Clinical Research [PDF]

open access: yesToxins
Pediatric torticollis, predominantly resulting from congenital muscular torticollis, is characterized by unilateral shortening of the sternocleidomastoid muscle, leading to head tilt and limited cervical mobility.
Na-Yoen Kwon   +2 more
doaj   +2 more sources

Botulinum toxin type A success rates and predictive factors for favourable outcomes in paediatric patients with acquired esotropia. [PDF]

open access: yesPLoS ONE
PurposeThis study aimed to assess the efficacy of botulinum toxin type A in treating childhood-acquired comitant esotropia and identify predictive factors of treatment success.MethodsThis retrospective, consecutive, non-comparative cohort study included ...
Narisa Rattanalert   +6 more
doaj   +2 more sources

Depression Treatment: Is There a Role for Botulinum Toxin Type A? [PDF]

open access: yesMicroorganisms
This study aimed to determine whether botulinum toxin type A injected into the muscles of the upper third of the face has antidepressant effects in patients diagnosed with depression.
Carmen Rodríguez-Cerdeira   +1 more
doaj   +2 more sources

Botulinum toxin preparations: areas for improvement and issues of standardisation

open access: yesБиопрепараты: Профилактика, диагностика, лечение, 2023
Scientific relevance. Botulinum toxin preparations are a good example of using a deadly toxin as a unique therapeutic agent. However, there are many unresolved issues related to biotechnology, biological activity, interchangeability, and standardisation ...
M. V. Savkina   +4 more
doaj   +1 more source

Prolonged Antipruritic Effect of Botulinum Toxin Type A on Cowhage-induced Itch: A Randomized, Single-blind, Placebo-controlled Trial

open access: yesActa Dermato-Venereologica, 2023
Botulinum toxin type A (Botox®) is thought to have antipruritic effects through inhibition of pruritic factors, including acetylcholine, substance P, and glutamate. The aim of this randomized, single-blind, placebo-controlled trial was to test the effect
Leigh A. Nattkemper   +7 more
doaj   +1 more source

Efficacy of botulinum toxin type B (rimabotulinumtoxinB) in patients with cervical dystonia previously treated with botulinum toxin type A: A post-marketing observational study in Japan

open access: yeseNeurologicalSci, 2021
To date, efficacy data on botulinum toxin type B (rimabotulinumtoxinB) in patients with cervical dystonia (CD) previously treated with botulinum toxin type A in a large population are lacking; thus, we aimed to evaluate type B efficacy in this patient ...
Ryuji Kaji   +3 more
doaj   +1 more source

Isolation and typing of Clostridium botulinum from milk powder of an enterprise associated with a case of infant botulism

open access: yesZhongguo shipin weisheng zazhi, 2023
ObjectiveThe aim of this study was to detect botulinum toxin and Clostridium botulinum (C.botulinum) in 30 batches of infant formula milk powder obtained from an enterprise and to analyze the whole genome of the strain of C.
LUO Haipeng   +8 more
doaj   +1 more source

Botulinum toxin type A therapy for blepharospasm [PDF]

open access: yesCochrane Database of Systematic Reviews, 2020
This is an update of a Cochrane Review first published in 2005. Blepharospasm is the second most common form of focal dystonia. It is a disabling disorder, characterised by chronic, intermittent or persistent, involuntary eyelid closure, due to spasmodic contractions of the orbicularis oculi muscles.
Duarte, GS   +7 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy